Constipation Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Chronic Idiopathic Constipation Market Share & Trends. The Market is Segmented by Therapeutics (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C Agonists, and Others), Disease Type (Chronic idiopathic constipation (CIC), Irritable bowel syndrome with constipation (IBS-C), and Opioid-induced constipation (OIC)), Distribution Channel (Hospital, Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, and the Middle East and Africa, and South America). The value is provided in (USD million) for the above segments.

INSTANT ACCESS

Constipation Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Constipation Treatment Industry Overview

The constipation treatment market is moderately fragmented and consists of several major players. Some of the companies which are currently dominating the market are Takeda Pharmaceutical Company Ltd., Ironwood Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Abbott Laboratories, AstraZeneca Plc, Cosmo Pharmaceuticals NV, Sanofi S.A., Bayer AG, Valeant Pharmaceuticals International Inc., Pfizer Inc., Synergy Pharmaceuticals, Inc., Janssen Pharmaceutical Company, and Boehringer Ingelheim GmbH.

Constipation Treatment Market Leaders

  1. Takeda Pharmaceutical Company Ltd

  2. Ironwood Pharmaceuticals, Inc.

  3. AstraZeneca Plc

  4. Salix Pharmaceuticals

  5. Sanofi S.A.

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.jpg

Constipation Treatment Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?